Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group

Radiolabeled metaiodobenzylguanidine (mIBG) is a highly sensitive and specific marker for detecting neuroblastoma. A semiquantitative mIBG score (Curie score [CS]) was assessed for utility as a prognostic indicator for a cohort of patients with highrisk metastatic disease. METHODS: mIBG scans from 2...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Nucl Med
Auteurs principaux: Yanik, Gregory A., Parisi, Marguerite T., Shulkin, Barry L., Naranjo, Arlene, Kreissman, Susan G., London, Wendy B., Villablanca, Judith G., Maris, John M., Park, Julie R., Cohn, Susan L., McGrady, Patrick, Matthay, Katherine K.
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5503147/
https://ncbi.nlm.nih.gov/pubmed/23440556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.112.112334
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires